Drug Profile
Nadorameran - CureVac
Alternative Names: CV-7201; CV-7201-mRNA; CV-7201-RNActive; RNActive® rabies vaccines - CureVacLatest Information Update: 28 Aug 2018
Price :
$50
*
At a glance
- Originator CureVac
- Class RNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Rabies
Most Recent Events
- 28 Aug 2018 No recent reports of development identified for phase-I development in Rabies(Prevention, In volunteers) in Germany (IM, Injection)
- 28 Aug 2018 No recent reports of development identified for phase-I development in Rabies(Prevention, In volunteers) in Germany (IM, Needle-free injection)
- 28 Aug 2018 No recent reports of development identified for phase-I development in Rabies(Prevention, In volunteers) in Germany (Intradermal, Injection)